Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial
Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page
- Check3 days agoChange DetectedA Lancet publication citation by Llibre et al. describing the SWORD-1 and SWORD-2 studies was removed from the Publications section of the NCT02429791 study page. The Publications section now lists fewer associated publications.SummaryDifference0.1%

- Check11 days agoChange Detected- The page now displays a recruitment status note No longer looking for participants and adds user guidance sections How to Read a Study Record, Common Questions, and How to Join a Study. - The label 'Intervention / Treatment' was removed and replaced with 'Intervention/Treatment'; the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page’s revision tag has been updated from v3.5.4 to v3.5.5, signaling a new site/template release rather than changes to the study details.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page's revision label in the footer was updated from v3.5.3 to v3.5.4, indicating a minor version update.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page’s displayed platform revision/version was updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check97 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the revision history.SummaryDifference0.0%

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.